Corticosteroids as adjunctive therapy in the treatment of influenza

Cochrane Database of Systematic Reviews

Volumn 2019, Issue 2, 2019, Pages

  Lansbury, Louise ^a   Rodrigo, Chamira ^b   Leonardi Bee, Jo ^a   Nguyen Van Tam, Jonathan ^c   Lim, Wei Shen ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CORTISONE; DEXAMETHASONE; HYDROCORTISONE; METHYLPREDNISOLONE; PLACEBO; PREDNISOLONE;

2009 H1N1 INFLUENZA; COMMUNITY ACQUIRED PNEUMONIA; DATA EXTRACTION; DOSAGE SCHEDULE COMPARISON; DRUG DOSE COMPARISON; DRUG FATALITY; DRUG INDICATION; DRUG MEGADOSE; EARLY INTERVENTION; FLU LIKE SYNDROME; GASTROINTESTINAL HEMORRHAGE; HAZARD RATIO; HOSPITAL INFECTION; HOSPITAL READMISSION; HUMAN; HYPERGLYCEMIA; HYPERNATREMIA; INFLUENZA; LENGTH OF STAY; LOW DRUG DOSE; MEDICAL RESEARCH; META ANALYSIS; MORTALITY; ODDS RATIO; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SAMPLE SIZE; SEPSIS; SYSTEMATIC ERROR; SYSTEMATIC REVIEW; THERAPY DELAY; TREATMENT DURATION; TREATMENT OUTCOME; ADJUVANT CHEMOTHERAPY; ARTIFICIAL VENTILATION; CROSS INFECTION; HOSPITAL MORTALITY; INFLUENZA A VIRUS (H1N1); INTENSIVE CARE UNIT; OBSERVATIONAL STUDY; STATISTICS AND NUMERICAL DATA;

ADRENAL CORTEX HORMONES; CHEMOTHERAPY, ADJUVANT; CROSS INFECTION; HOSPITAL MORTALITY; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INTENSIVE CARE UNITS; OBSERVATIONAL STUDIES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATION, ARTIFICIAL;

EID: 85062366949     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD010406.pub3     Document Type: Review

References (138)

1. Al-Busaidi M, Al Maamari K, Al'Adawi B, Ba Alawi F, Al-Wahaibi A, Belkhair A,. Pandemic influenza a H1N1 in Oman: epidemiology, clinical features, and outcome of patients admitted to Sultan Qaboos University Hospital in 2009. Oman Medical Journal 2016; 31 (4): 290-7. 10109788
2. Balaganesakumar SR, Murhekar MV, Swamy KK, Kumar MR, Manickam P, Pandian P,. Risk factors associated with death among influenza A (H1N1) patients, Tamil Nadu, India, 2010. Journal of Postgraduate Medicine 2013; 59 (1): 9-14. 2880611
3. Boudreault A, Xie H, Leisenring W, Englund J, Corey L, Boeckh M,. Impact of corticosteroid treatment and antiviral therapy on clinical outcomes in hematopoietic cell transplant patients infected with influenza virus. Biology of Blood and Marrow Transplantation 2011; 17 (7): 979-86. 2880613
4. Brun-Buisson C, Jean-Christophe M, Mercat A, Thiebaut A, Brochard L,. Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine 2011; 183 (9): 1200-6. 2880615
5. Cao B, Gao H, Zhou BP, Deng XL, Hu CP, Deng CS, et al., Adjuvant corticosteroid treatment in adults with influenza A (H7N9) viral pneumonia. Critical Care Medicine 2016; 44 (6): E318-28. 10109790
6. Chawla R, Kansal S, Chauhan M, Jain A, Jibhkate B,. Predictors of mortality and length of stay in hospitalized cases of 2009 influenza A (H1N1): experiences of a tertiary care center. Indian Journal of Critical Care Medicine 2013; 17 (5): 275-82. 2880617
7. Delaney JW, Pinto R, Long J, Lamontagne F, Adhikari NK, Kumar A, et al., The influence of corticosteroid treatment on the outcome of influenza A (H1N1pdm09)-related critical illness. Critical Care 2016; 20 (75): 1-11. [DOI: 10.1186/s13054-016-1230-8 ] 10109792
8. Delgado-Rodriguez M, Castilla J, Godoy P, Martin V, Soldevila N, Alonso J, et al., Prognosis of hospitalized patients with 2009 H1N1 influenza in Spain: influence of neuraminidase inhibitors. Journal of Antimicrobial Chemotherapy 2012; 67 (7): 1739-45. 2880619
9. Han K, Ma H, An X, Su Y, Chen J, Lian Z, et al., Early use of glucocorticoids was a risk factor for critical disease and death from pH1N1 infection. Clinical Infectious Diseases 2011; 53 (4): 326-33. 2880623
10. Huang SF, Fung CP, Perng DW, Wang FD,. Effects of corticosteroid and neuraminidase inhibitors on survival in patients with respiratory distress induced by influenza virus. Journal of Microbiology, Immunology and Infection 2017; 50 (5): 586-94. 10109794
11. Jain S, Kamimoto L, Bramley A, Schmitz A, Benoit S, Louie J, et al., Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. New England Journal of Medicine 2009; 361 (20): 1935-44. 2880625
12. Kim S, Hong S, Yun S, Choi W, Ahn J, Lee Y, et al., Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection: analytic strategy using propensity scores. American Journal of Respiratory and Critical Care Medicine 2011; 183 (9): 1207-14. 2880627
13. Kinikar AA, Kulkarni RK, Valvi CT, Mave V, Gupte N, Khadse S, et al., Predictors of mortality in hospitalized children with pandemic H1N1 influenza 2009 in Pune, India. Indian Journal of Pediatrics 2012; 79 (4): 459-66. 10109796
14. Kudo K, Takasaki J, Manabe T, Uryu H, Yamada R, Kuroda E, et al., Systemic corticosteroids and early administration of antiviral agents for pneumonia with acute wheezing due to influenza A (H1N1) pdm09 in Japan. PLOS ONE 2012; 7 (2): e32280. 2880629
15. Lee N, Leo YS, Cao B, Chan PK, Kyaw WM, Uyeki TM, et al., Neuraminidase inhibitors, superinfection and corticosteroids affect survival of influenza patients. European Respiratory Journal 2015; 45 (6): 1642-52. 10109798
16. Li F, Chen G, Wang J, Liu H, Wu J,. A case-control study on risk factors associated with death in pregnant women with severe pandemic H1N1 infection. BMJ Open 2012; 2 (4): e000827. 2880631
17. Li H, Yang SG, Gu L, Zhang Y, Yan XX, Liang ZA, et al., Effect of low-to-moderate-dose corticosteroids on mortality of hospitalized adolescents and adults with influenza A (H1N1) pdm09 viral pneumonia. Influenza and Other Respiratory Viruses 2017; 11 (4): 345-54. 10109800
18. Liem N, Tung C, Hien N, Hien T, Chau N, Long H, et al., Clinical features of human influenza A (H5N1) infection in Vietnam: 2004-2006. Clinical Infectious Diseases 2009; 48 (12): 1639-46. 2880633
19. Linko R, Pettila V, Ruokonen E, Varpula T, Karlsson S, Tenhunen J, et al., Corticosteroid therapy in intensive care unit patients with PCR-confirmed influenza A (H1N1) infection in Finland. Acta Anaesthesiologica Scandinavica 2011; 55 (8): 971-9. 2880635
20. Mady A, Ramadan O, Yousef A, Mandourah Y, Amr A, Kherallah M,. Clinical experience with severe 2009 H1N1 influenza in the intensive care unit at King Saud Medical City, Saudi Arabia. Journal of Infection and Public Health 2012; 5 (1): 52-6. 2880637
21. Moreno G, Rodriguez A, Reyes LF, Gomez J, Sole-Violan J, Diaz E, et al., Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study. Intensive Care Medicine 2018; 44 (9): 1470-82. 10109802
22. Ono S, Ono Y, Matsui H, Yasunaga H,. Factors associated with hospitalization for seasonal influenza in a Japanese nonelderly cohort. BMC Public Health 2016; 16: 922. 10109804
23. Patel K, Patel A, Mehta P, Amin R, Patel K, Chuhan P, et al., Clinical outcome of novel H1N1 (swine flu)-infected patients during 2009 pandemic at tertiary referral hospital in western India. Journal of Global Infectious Diseases 2013; 5 (3): 93-7. 2880639
24. Sertogullarindan B, Ozbay B, Gunini H, Sunnetcioglu A, Arisoy A, Bilgin HM, et al., Clinical and prognostic features of patients with pandemic 2009 influenza a (H1N1) virus in the intensive care unit. African Health Sciences 2011; 11 (2): 163-70. 2880641
25. Sheu C-C, Chang W-A, Tsai M-J, Tsai J-R, Chong I-W,. Early corticosteroid treatment in patients with influenza-associated acute respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine 2017; 195: A2769. [A2769] 10109806
26. Viasus D, Pano-Pardo J, Cordero E, Campins A, Lopez-Medrano F, Villoslada A, et al., Effect of immunomodulatory therapies in patients with pandemic influenza A (H1N1) 2009 complicated by pneumonia. Journal of Infection 2011; 62 (3): 193-9. 2880643
27. Wirz SA, Blum CA, Schuetz P, Albrich WC, Noppen C, Mueller B, et al., Pathogen- and antibiotic-specific effects of prednisone in community-acquired pneumonia. European Respiratory Journal 2016; 48 (4): 1150-9. 10109808
28. Wu U, Wang J, Ho Y, Pan S, Chen Y, Chang S,. Factors associated with development of complications among adults with influenza: a 3-year prospective analysis. Journal of the Formosan Medical Association 2012; 111 (7): 364-9. 2880645
29. Xi X, Xu Y, Jiang L, Li A, Duan J, Du B, et al., Hospitalized adult patients with 2009 influenza A (H1N1) in Beijing, China: risk factors for hospital mortality. BMC Infectious Diseases 2010; 10: 256. 2880647
30. Yu H-T, Yang Y-J, Zhang Q-X, Jia J-G, Chen Q-S, Zang J-P, et al., Clinical characteristics and risk factors of severe patients with novel pandemic influenza A H1N1. Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care 2011; 18 (3): 142-5. 10109810
31. Chan W, Chang K, Loung P, Lai C, Tse W,. Serious pandemic influenza A/H1N1 infection in paediatric intensive care unit from 2009-2014. Hong Kong Journal of Paediatrics 2014; 19: 199-200. 2880649
32. Chen K, Li YJ, Li KZ, Wu ZX, Ning B, Lu LJ,. Glucocorticoid treatment on severe A/H1N1 influenza. Chinese Journal of Nosocomiology 2010; 20: 3149-51. 10109812
33. Chien YS, Su CP, Tsai HT, Huang AS, Lien CE, Hung MN, et al., Predictors and outcomes of respiratory failure among hospitalized pneumonia patients with 2009 H1N1 influenza in Taiwan. Journal of Infection 2010; 60 (2): 168-74. 10109814
34. Chotpitayasunondh T, Ungchusak K, Hanshaoworakul W, Chunsuthiwat S, Sawanpanyalert P, Kijphati R, et al., Human disease from influenza A (H5N1), Thailand, 2004. Emerging Infectious Diseases 2005; 11 (2): 201-9. 10109816
35. Diaz E, Martin-Loeches I, Canadell L, Vidaur L, Suarez D, Socias L, et al., Corticosteroid therapy in patients with primary viral pneumonia due to pandemic (H1N1) 2009 influenza. Journal of Infection 2012; 64 (3): 311-8. 2880621
36. Dominguez-Cherit G, De la Torre A, Rishu A, Pinto R, Ñamendys-Silva SA, Camacho-Ortiz A, et al., Influenza A (H1N1pdm09)-related critical illness and mortality in Mexico and Canada, 2014. Critical Care Medicine 2016; 44 (10): 1861-70. 10109818
37. Fujikura Y, Kawano S, Kouzaki Y, Shinoda M, Hara Y, Shinkai M, et al., The (H1N1) 2009 pandemic influenza pneumonia among adult patients in Japan. Japanese Journal of Infectious Diseases 2014; 67 (2): 100-4. 2880651
38. Gao H, Lu H, Cao B, Du B, Shang H, Gan J, et al., Clinical findings in 111 cases of influenza A (H7N9) virus infection. New England Journal of Medicine 2013; 368 (24): 2277-85. 2880653
39. Garnacho-Montero J, Gutierrez-Pizarraya A, Marquez J, Zaragoza R, Granada R, Ruiz-Santana S, et al., Epidemiology, clinical features, and prognosis of elderly adults with severe forms of influenza A (H1N1). Journal of the American Geriatrics Society 2013; 61 (3): 350-6. 2880655
40. Hien ND, Ha NH, Van NT, Ha NT, Lien TT, Thai NQ, et al., Human infection with highly pathogenic avian influenza virus (H5N1) in northern Vietnam, 2004-2005. Emerging Infectious Diseases 2009; 15 (1): 19-23. 10109820
41. Hong SB, Choi EY, Kim SH, Suh GY, Park MS, Lee MG, et al., Epidemiological analysis of critically ill adult patients with pandemic influenza A (H1N1) in South Korea. Epidemiology and Infection 2013; 141 (5): 1070-9. 10109822
42. Hu Y, Lu S, Song Z, Wang W, Hao P, Li J, et al., Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. Lancet 2013; 381 (9885): 2273-9. 2880657
43. Jung JY, Park BH, Hong SB, Koh Y, Suh GY, Jeon K, et al., Acute kidney injury in critically ill patients with pandemic influenza A pneumonia 2009 in Korea: a multicenter study. Journal of Critical Care 2011; 26 (6): 577-85. 10109824
44. Leon Moya C, Gutierrez Pizarraya A, Canton Bulnes ML, Arenzana Seisdedos A, Rodriguez A, Garnacho-Montero J,. Characteristics of immunocompromised patients with influenza A virus admitted to the intensive care unit. Intensive Care Medicine Experimental 2017; 5 (Suppl 2): 1027. 10109826
45. Martin-Loeches I, Bermejo-Martin J, Valles J, Granada R, Vidaur L, Vergara-Serrano J, et al., Macrolide-based regimens in absence of bacterial co-infection in critically ill H1N1 patients with primary viral pneumonia. Intensive Care Medicine 2013; 39 (4): 693-702. 2880659
46. McKenna J, Bramley A, Skarbinski J, Fry A, Finelli L, Jain S,. Asthma in patients hospitalized with pandemic influenza A (H1N1) pdm09 virus infection-United States, 2009. BMC Infectious Diseases 2013; 13: 57. 2880661
47. Ning J,. Diagnosis and treatment of children with severe influenza A from the 2009/2010 pandemic in Tianjin, China. Tropical Doctor 2014; 44 (2): 69-70. 2880663
48. Okur M, Erbey F, Yazicioglu O, Celik A, Tukenmez B, Sunnetcioglu M,. H1N1 influenza A virus related pneumonia and respiratory failure. Indian Journal of Virology 2013; 24 (1): 85-9. 2880665
49. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, Hernandez M, Quinones-Falconi F, Bautista E, et al., Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. New England Journal of Medicine 2009; 361 (7): 680-9. 10109828
50. Rios FG, Estenssoro E, Villarejo F, Valentini R, Aguilar L, Pezzola D, et al., Lung function and organ dysfunctions in 178 patients requiring mechanical ventilation during the 2009 influenza A (H1N1) pandemic. Critical Care 2011; 15 (4): R201. 10109830
51. Segaloff HE, Evans R, Arshad S, Zervos MJ, Archer C, Kaye KS, et al., The impact of obesity and timely antiviral administration on severe influenza outcomes among hospitalized adults. Journal of Medical Virology 2018; 90 (2): 212-8. 10109832
52. Singh A, Khera K, Agarwal J, Awasthi S, Francis JM, Thunga G, et al., Descriptive analysis of mortality predictors in H1n1 influenza in south Indian patients. Infectious Disorders-Drug Targets 2017; 17 (2): 106-15. 10109834
53. Smud A, Nagel C, Madsen E, Rial M, Barcan L, Gomez A, et al., Pandemic influenza a/H1N1 virus infection in solid organ transplant recipients: a multicenter study. Transplantation 2010; 90 (12): 400. 2880667
54. Sun JJ, Li C, Wu DW, Li CH, Qin WH, Li YL, et al., Eighteen cases of 2009 influenza A H1N1 associated with respiratory failure in adults. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue [Chinese Critical Care Medicine] 2010; 22 (3): 156-60. 10109836
55. Torres SF, Iolster T, Schnitzler EJ, Farias JA, Bordogna AC, Rufach D, et al., High mortality in patients with influenza A pH1N1 2009 admitted to a pediatric intensive care unit: a predictive model of mortality. Pediatric Critical Care Medicine 2012; 13 (2): e78-83. 10109838
56. Vilar-Compte D, Shah DP, Vanichanan J, Cornejo-Juarez P, Garcia-Horton A, Volkow P, et al., Influenza in patients with hematological malignancies: experience at two comprehensive cancer centers. Journal of Medical Virology 2018; 90 (1): 50-60. 10109840
57. Yale P, Adhikari NK, Masse V, Fowler RA, Xiong W, McGeer A, et al., Corticosteroid therapy in critical illness due to seasonal and pandemic influenza. Canadian Respiratory Journal 2015; 22 (5): 271-4. 10109842
58. Yang Y, Guo F, Zhao W, Gu Q, Huang M, Cao Q, et al., Novel avian-origin influenza a (H7N9) in critically ill patients in China. Critical Care Medicine 2015; 43 (2): 339-45. 10109844
59. Zhang X-D, Chen W-W, Yin X-G, Zhang C, Li R, Li G-M, et al., Retrospective analysis of 146 severe or critically ill patients with influenza A H1N1. Journal of Kunming Medical University 2011; 4: 136-41. 10109846
60. Zhang PJ, Cao B, Li XL, Liang LR, Yang SG, Gu L, et al., Risk factors for adult death due to 2009 pandemic influenza A (H1N1) virus infection: a 2151 severe and critical cases analysis. Chinese Medical Journal 2013; 126 (12): 2222-8. 10109848
61. Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, et al., Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288 (7): 862-71. [PUBMED: 12186604]
62. Annane D, Bellissant E, Bollaert P, Briegel J, Keh D, Kupfer Y,. Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. BMJ 2004; 329 (7464): 480. [DOI: 10.1136/bmj.38181.482222.55 ]
63. Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y,. Corticosteroids for treating sepsis. Cochrane Database of Systematic Reviews 2015, Issue 12. [DOI: 10.1002/14651858.CD002243.pub3 ]
64. Annane D, Pastores SM, Arlt W, Balk RA, Beishuizen A, Briegel J, et al., Critical illness-related corticosteroid insufficiency (CIRCI): a narrative review from a Multispecialty Task Force of the Society of Critical Care Medicine (SCCM) and the European Society of Intensive Care Medicine (ESICM). Intensive Care Medicine 2017; 43 (12): 1781-92.
65. Annane D, Renault A, Brun-Buisson C, Megarbane B, Quenot JP, Siami S, et al., Hydrocortisone plus fludrocortisone for adults with septic shock. New England Journal of Medicine 2018; 378 (9): 809-18.
66. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al., Grading quality of evidence and strength of recommendations. BMJ (Clinical research ed.) 2004; 328 (7454): 1490. [PUBMED: 15205295]
67. Bi J, Yang J, Wang Y, Yao C, Mei J, Liu Y, et al., Efficacy and safety of adjunctive corticosteroids therapy for severe community-acquired pneumonia in adults: an updated systematic review and meta-analysis. PLOS ONE 2016; 11 (11): e0165942.
68. Brouwer MC, McIntyre P, Prasad K, van de Beek D,. Corticosteroids for acute bacterial meningitis. Cochrane Database of Systematic Reviews 2015, Issue 9. [DOI: 10.1002/14651858.CD004405.pub5 ]
69. British Thoracic Society/Scottish Intercollegiate Guidelines Network. BTS/SIGN British guideline for the management of asthma, 2016, SIGN 153. www.sign.ac.uk/sign-153-british-guideline-on-the-management-of-asthma.html (accessed prior to 12 February 2019).
70. Cain DW, Cidlowski JA,. Immune regulation by glucocorticoids. Nature Reviews Immunology 2017; 17 (4): 233-47.
71. Caini S, Andrade W, Badur S, Balmaseda A, Barakat A, Bella A, et al., Temporal patterns of influenza A and B in tropical and temperate countries: what are the lessons for influenza vaccination?. PLOS ONE 2016; 11 (3): e0152310.
72. Chen LP, Chen JH, Chen Y, Wu C, Yang XH,. Efficacy and safety of glucocorticoids in the treatment of community-acquired pneumonia: a meta-analysis of randomized controlled trials. World Journal of Emergency Medicine 2015; 6 (3): 172-8.
73. Choi SM, Boudreault A, Xie H, Englund J, Corey L, Boeckh M,. Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients. Blood 2011; 117 (19): 5050-6.
74. Coutinho AE, Chapman KE,. The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Molecular and Cellular Endocrinology 2011; 335 (1): 2-13.
75. Cromer D, van Hoek AJ, Jit M, Edmunds WJ, Fleming D, Miller E,. The burden of influenza in England by age and clinical risk group: a statistical analysis to inform vaccine policy. Journal of Infection 2014; 68 (4): 363-71. [PUBMED: 24291062]
76. Dawood F, Iuliano A, Reed C, Meltzer M, Shay D, Cheng P-Y,. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infectious Diseases 2012; 12 (9): 687-95.
77. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, et al., Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nature Medicine 2006; 12 (10): 1203-7.
78. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al., Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Critical Care Medicine 2013; 41 (2): 580-637.
79. Deyde V, Xu X, Bright R, Shaw M, Smith C, Zhang Y,. Surveillance of resistance to adamantanes among influenza A (H3N2) and A (H1N1) viruses isolated worldwide. Journal of Infectious Diseases 2007; 196 (2): 249-57.
80. Donaldson LJ, Rutter PD, Ellis BM, Greaves FE, Mytton OT, Pebody RG, et al., Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study. BMJ 2010; 339: b5213. [DOI: 10.1136/bmj.b5213 ]
81. Fernandes RM, Bialy LM, Vandermeer B, Tjosvold L, Plint AC, Patel H, et al., Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database of Systematic Reviews 2013, Issue 6. [DOI: 10.1002/14651858.CD004878.pub4 ]
82. Gates A, Gates M, Vandermeer B, Johnson C, Hartling L, Johnson DW,. Glucocorticoids for croup in children. Cochrane Database of Systematic Reviews 2018, Issue 8. [DOI: 10.1002/14651858.CD001955.pub4 ]
83. Giannella M, Alonso M, Garcia de Viedma D, Lopez Roa P, Catalan P, Padilla B, et al., Prolonged viral shedding in pandemic influenza A (H1N1): clinical significance and viral load analysis in hospitalized patients. Clinical Microbiology & Infection 2011; 17 (8): 1160-5.
84. McMaster University (developed by Evidence Prime). GRADEpro GDT. Version accessed 22 October 2018. Hamilton (ON): McMaster University (developed by Evidence Prime), 2014.
85. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al., GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology 2011; 64 (4): 383-94.
86. Heltzer ML, Coffin SE, Maurer K, Bagashev A, Zhang Z, Orange JS, et al., Immune dysregulation in severe influenza. Journal of Leukocyte Biology 2009; 85 (6): 1036-43.
87. Higgins JP, Green S (editors),. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
88. Horita N, Otsuka T, Haranaga S, Namkoong H, Miki M, Miyashita N, et al., Adjunctive systemic corticosteroids for hospitalized community-acquired pneumonia: systematic review and meta-analysis 2015 update. Scientific Reports 2015; 5: 14061.
89. Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S, et al., Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet 2018; 391 (10127): 1285-300.
90. Jefferson T, Jones M, Doshi P, Del Mar C, Heneghan C, Hama R, et al., Neuraminidase inhibitors for preventing and treating influenza in adults and children. Cochrane Database of Systematic Reviews 2014, Issue 4. [DOI: 10.1002/14651858.CD008965.pub4 ]
91. Kaufmann, Briegel J, Schliephake F, Hoelzl AC, Alexander H, Theresia S, et al., Stress doses of hydrocortisone in septic shock: beneficial effects on opsonization-dependent neutrophil functions. Intensive Care Medicine 2008; 34 (2): 344-9.
92. Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J,. Critically ill patients with 2009 influenza A (H1N1) infection in Canada. JAMA 2009; 302 (17): 1872-9.
93. Lamontagne F, Rochwerg B, Lytvyn L, Guyatt GH, Møller MH, Annane D, et al., Corticosteroid therapy for sepsis: a clinical practice guideline. BMJ 2018; Vol. 362: k3284.
94. Lee N, Chan P, Hui D, Rainer T, Wong E, Choi KW, et al., Viral loads and duration of viral shedding in adult patients hospitalized with influenza. Journal of Infectious Diseases 2009; 200 (4): 492-500.
95. Lee N, Wong CK, Chan PK, Chan MC, Wong RY, Lun SW, et al., Cytokine response patterns in severe pandemic 2009 H1N1 and seasonal influenza among hospitalized adults. PLOS ONE 2011; 6 (10): e26050.
96. Lefebvre C, Manheimer E, Glanville J,. Chapter 6: Searching for studies. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
97. Marik PE,. Critical illness-related corticosteroid insufficiency. Chest 2009; 135 (1): 181-93.
98. Marti C, Grosgurin O, Harbarth S, Combescure C, Abbas M, Rutschmann O, et al., Adjunctive corticotherapy for community acquired pneumonia: a systematic review and meta-analysis. PLOS ONE 2015; 10 (12): e0144032.
99. Martin-Loeches I, Lisboa T, Rhodes A, Moreno RP, Silva E, Sprung C, et al., Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1) influenza A infection. Intensive Care Medicine 2010; 37 (2): 272-83. [DOI: 10.1007/s00134-010-2078-z ]
100. McClain MT, Henao R, Williams J, Nicholson B, Veldman T, Hudson L, et al., Differential evolution of peripheral cytokine levels in symptomatic and asymptomatic responses to experimental influenza virus challenge. Clinical and Experimental Immunology 2016; 183 (3): 441-51.
101. Molenaar N, Bijkerk RM, Beishuizen A, Hempen CM, de Jong MF, Vermes I, et al., Steroidogenesis in the adrenal dysfunction of critical illness: impact of etomidate. Critical Care 2012; 16 (4): 1-9.
102. Muthuri SG, Myles PR, Venkatesan S, Leonardi-Bee J, Nguyen-Van-Tam JS,. Impact of neuraminidase inhibitor treatment on outcomes of public health importance during the 2009-2010 influenza A (H1N1) pandemic: a systematic review and meta-analysis in hospitalized patients. Journal of Infectious Diseases 2013; 207 (4): 553-63.
103. Myles P, Nguyen-Van-Tam JS, Semple MG, Brett SJ, Bannister B, Read R, et al., Differences between asthmatics and nonasthmatics hospitalised with influenza A infection. European Respiratory Journal 2013; 41 (4): 824-31.
104. NCT01743755,. Santeon-CAP; Dexamethasone in community-acquired pneumonia. clinicaltrials.gov/ct2/show/study/NCT01743755?term=SANTEON&rank=1 (first received 22 November 2012).
105. NCT02517489,. Community-acquired pneumonia: evaluation of corticosteroids [Effects of low-dose corticosteroids on survival of severe community-acquired pneumonia]. clinicaltrials.gov/ct2/show/study/NCT02517489?term=CAPE+COD&rank=3 (first received 31 July 2015).
106. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al., The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. www.ohri.ca/programs/clinical-epidemiology/oxford.asp (accessed prior to 12 February 2019).
107. Nguyen-Van-Tam JS, Openshaw PJ, Hashim A, Gadd EM, Lim WS, Semple MG, et al., Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009). Thorax 2010; 65 (7): 645-51. [PUBMED: 20627925]
108. National Institute for Health and Care Excellence. Chronic obstructive pulmonary disease in over 16s: diagnosis and management. www.nice.org.uk/guidance/CG101 June 2010 (accessed prior to 12 February 2019).
109. Ortiz JR, Rudd KE, Clark DV, Jacob S, West TE,. Clinical research during a public health emergency: a systematic review of severe pandemic influenza management. Critical Care Medicine 2013; 41 (5): 1345-52.
110. Ortiz JR, Neuzil KM, Shay DK, Rue TC, Neradilek MB, Zhou H, et al., The burden of influenza-associated critical illness hospitalizations. Critical Care Medicine 2014; 42 (11): 2325-32. [PUBMED: 25148596]
111. Peasah SK, Azziz-Baumgartner E, Breese J, Meltzer MI, Widdowson MA,. Influenza cost and cost-effectiveness studies globally-a review. Vaccine 2013; 31 (46): 5339-48. [PUBMED: 24055351]
112. Prasad K, Singh MB, Ryan H,. Corticosteroids for managing tuberculous meningitis. Cochrane Database of Systematic Reviews 2016, Issue 4. [DOI: 10.1002/14651858.CD002244.pub4 ]
113. Quispe-Laime A, Bracco J, Barberio P, Campagne C, Rolfo V, Umberger R, et al., H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment. Intensive Care Medicine 2010; 36 (1): 33-41.
114. Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
115. Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al., Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Medicine 2017; 43 (3): 304-77.
116. Richard J, Pham T, Brun-Buisson C, Reignier J, Mercat A, Beduneau G,. Interest of a simple on-line screening registry for measuring ICU burden related to an influenza pandemic. Critical Care 2012; 16 (4): 1-10.
117. Rochwerg B, Oczkowski SJ, Siemieniuk RAC, Agoritsas T, Belley-Cote E, D'Aragon F, et al., Corticosteroids in sepsis: an updated systematic review and meta-analysis. Critical Care Medicine 2018; 46 (9): 1411-20.
118. Schulz KF, Altman DG, Moher D,. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010; 340 (c332): 698-702. [DOI: 10.1136/bmj.c332 ]
119. Siemieniuk RA, Meade MO, Alonso-Coello P, Briel M, Evaniew N, Prasad M, et al., Corticosteroid therapy for patients hospitalized with community-acquired pneumonia: a systematic review and meta-analysis. Annals of Internal Medicine 2015; 163 (7): 519-28. [PUBMED: 26258555]
120. Scottish Intercollegiate Guidelines Network (SIGN). Search filters, observational studies. www.sign.ac.uk/search-filters.html (accessed 14 November 2017).
121. Stern A, Skalsky K, Avni T, Carrara E, Leibovici L, Paul M,. Corticosteroids for pneumonia. Cochrane Database of Systematic Reviews 2017, Issue 12. [DOI: 10.1002/14651858.CD007720.pub3 ]
122. Taubenberger J, Morens D,. The pathology of influenza virus infections. Annual Review of Pathology: Mechanisms of Disease 2008; 3 (1): 499-522.
123. To K, Hung I, Li I, Lee K, Koo C, Yan W, et al., Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clinical Infectious Diseases 2010; 50 (6): 850-9.
124. Venekamp RP, Thompson MJ, Hayward G, Heneghan CJ, Del Mar CB, Perera R, et al., Systemic corticosteroids for acute sinusitis. Cochrane Database of Systematic Reviews 2014, Issue 3. [DOI: 10.1002/14651858.CD008115.pub3 ]
125. Venkatesh B, Finfer S, Cohen J, Rajbhandari D, Arabi Y, Bellomo R, et al., Adjunctive glucocorticoid therapy in patients with septic shock. New England Journal of Medicine 2018; 378 (9): 797-808.
126. Viboud C, Miller M, Olson D, Osterholm M, Simonsen L,. Preliminary estimates of mortality and years of life lost associated with the 2009 A/H1N1 pandemic in the US and comparison with past influenza seasons. PLOS Currents 2010; 2: RRN1153. [DOI: 10.1371/currents.RRN1153 ]
127. Wan YD, Sun TW, Liu ZQ, Zhang SG, Wang LX, Kan QC,. Efficacy and safety of corticosteroids for community-acquired pneumonia: a systematic review and meta-analysis. Chest 2016; 149 (1): 209-19.
128. Wauters J, Baar I, Meersseman P, Meersseman W, Dams K, De Paep R, et al., Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study. Intensive Care Medicine 2012; 38 (11): 1761-8.
129. The Writing Committee of the World Health Organization (WHO) Consultation on Human Influenza A/H5. Avian influenza A (H5N1) infection in humans. New England Journal of Medicine 2005; 353 (13): 1374-85.
130. World Health Organization. WHO guidelines for the pharmacological management of pandemic influenza A(H1N1) 2009 and other influenza viruses. www.who.int/csr/resources/publications/swineflu/h1n1-guidelines-pharmaceutical-mngt.pdf?ua=1 2010 (accessed prior to 12 February 2019).
131. World Health Organization. Influenza (Seasonal). www.who.int/news-room/fact-sheets/detail/influenza-(seasonal) (accessed 23 October 2018).
132. Wu WF, Fang Q, He GJ,. Efficacy of corticosteroid treatment for severe community-acquired pneumonia: a meta-analysis. American Journal of Emergency Medicine 2018; 36 (2): 179-84.
133. Yang JW, Fan LC, Miao XY, Mao B, Li MH, Lu HW, et al., Corticosteroids for the treatment of human infection with influenza virus: a systematic review and meta-analysis. Clinical Microbiology and Infection 2015; 21 (10): 956-63.
134. Yu X, Zhang X, Zhao B, Wang J, Zhu Z, Teng Z, et al., Intensive cytokine induction in pandemic H1N1 influenza virus infection accompanied by robust production of IL-10 and IL-6. PLOS ONE 2011; 6 (12): e28680. [DOI: 10.1371/journal.pone.0028680 ]
135. Zhang Y, Sun WJ, Svendsen ER, Tang S, MacIntyre RC, Yang P, et al., Do corticosteroids reduce the mortality of influenza A (H1N1) infection? A meta-analysis. Critical Care 2015; 19 (1): 46. [DOI: 10.1186/s13054-015-0764-5 ]
136. Zhou H, Thompson WW, Viboud CG, Ringholz CM, Cheng PY, Steiner C, et al., Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clinical Infectious Diseases 2012; 54 (10): 1427-36. [PUBMED: 22495079]
137. Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam J, Lim WS,. Corticosteroids as adjunctive therapy in the treatment of influenza. Cochrane Database of Systematic Reviews 2013, Issue 2. [DOI: 10.1002/14651858.CD010406 ]
138. Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam J, Lim WS,. Corticosteroids as adjunctive therapy in the treatment of influenza. Cochrane Database of Systematic Reviews 2016, Issue 3. [DOI: 10.1002/14651858.CD010406.pub2 ]